Cargando…

Racial variation in lipoprotein-associated phospholipase A(2 )in older adults

BACKGROUND: Lipoprotein-associated phospholipase A(2 )(Lp-PLA(2)) is a predictor of cardiovascular events that has been shown to vary with race. The objective of this study was to examine factors associated with this racial variation. METHODS: We measured Lp-PLA(2 )mass and activity in 714 healthy o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Keane K, Fortmann, Stephen P, Varady, Ann, Fair, Joan M, Go, Alan S, Quertermous, Thomas, Hlatky, Mark A, Iribarren, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146402/ https://www.ncbi.nlm.nih.gov/pubmed/21714927 http://dx.doi.org/10.1186/1471-2261-11-38

Ejemplares similares

Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: A cohort study
por: Bansal, Nisha, et al.
Publicado: (2011)

Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients
por: Banerjee, Dipanjan, et al.
Publicado: (2011)

Peroxisome Proliferator-Activated Receptor Gamma Polymorphisms and Coronary Heart Disease
por: Dallongeville, Jean, et al.
Publicado: (2009)

Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD
por: Knowles, Joshua W, et al.
Publicado: (2008)

Right coronary wall cmr in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium
por: Terashima, Masahiro, et al.
Publicado: (2010)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Characterizing the admixed African ancestry of African Americans
por: Zakharia, Fouad, et al.
Publicado: (2009)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum
por: Feng, Li-Min, et al.
Publicado: (2014)

Secreted phospholipase A(2), lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics
por: Yamamoto, Kei, et al.
Publicado: (2011)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Racial differences in cigarette brand recognition and impact on youth smoking
por: Dauphinee, Amanda L, et al.
Publicado: (2013)

Familial Resemblance in Low‐Density Lipoprotein Cholesterol Response to Statins in the Danish Population
por: Corn, Giulia, et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Is lipoprotein-associated phospholipase A(2) correlated with cardiovascular risk in European women?
por: Hirschler, V.
Publicado: (2013)

Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories
por: Dhamoon, Mandip S., et al.
Publicado: (2019)

The correlation between lipoprotein associated phospholipase A(2) and central overweight status
por: Chen, Yi-Hsuan, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A(2): A paradigm for allosteric regulation by membranes
por: Mouchlis, Varnavas D., et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy
por: Zhai, Yan, et al.
Publicado: (2023)

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

REGIONAL VARIATIONS IN ENGAGEMENT IN ADVANCE CARE PLANNING AMONG RACIALLY AND ETHNICALLY DIVERSE OLDER ADULTS
por: Kim, Kyeongmo, et al.
Publicado: (2019)

Active site competition is the mechanism for the inhibition of lipoprotein-associated phospholipase A(2) by detergent micelles or lipoproteins and for the efficacy reduction of darapladib
por: Zhuo, Shaoqiu, et al.
Publicado: (2020)

Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011)

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

Ambient Air Pollution and Lipoprotein-Associated Phospholipase A(2) in Survivors of Myocardial Infarction
por: Brüske, Irene, et al.
Publicado: (2011)

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease
por: LI, SHUAI-BING, et al.
Publicado: (2013)

The Role of Lipoprotein-Associated Phospholipase A₂ in a Murine Model of Experimental Autoimmune Uveoretinitis
por: Crawford, G. L., et al.
Publicado: (2015)

Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
por: Wang, Youxin, et al.
Publicado: (2018)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
por: Zhang, Hao, et al.
Publicado: (2020)

The role of lipoprotein-associated phospholipase A2 in acute kidney injury of septic mice
por: Liang, Guiwen, et al.
Publicado: (2020)

Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson’s Disease
por: Wu, Zubo, et al.
Publicado: (2021)

Biological Properties and Clinical Significance of Lipoprotein-Associated Phospholipase A(2) in Ischemic Stroke
por: Zhang, Shuang, et al.
Publicado: (2022)

Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein‐Associated Phospholipase A(2)
por: Fenning, Robert S., et al.
Publicado: (2015)

Racial/ethnic/gender-based Disparities in Health Trajectories among American Older Adults
por: Kong, Dexia, et al.
Publicado: (2020)

Geographic Variation in Racial Disparities in Receipt of High-Dose Influenza Vaccine Among US Older Adults
por: Silva, Joe B.B., et al.
Publicado: (2023)

The effect of lipoprotein-associated phospholipase A(2) deficiency on pulmonary allergic responses in aspergillus fumigatus sensitized mice
por: Jiang, Zhilong, et al.
Publicado: (2012)

Racial Variations in Immunity to Syphilis
por: Bowen, H. E.
Publicado: (1948)

Racial inequities and biopsychosocial indicators in older adults
por: Bolina, Alisson Fernandes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6u054d3m8496u5ijlakrdpabmr